{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3320, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/15", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "other", "function": "analyze_data", "notes": "The DLS screen shows hydrodynamic radius (Rh) over time for various buffers; the accelerated stress screen compares 0-week vs 2-week stability across four buffer conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/16", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "The slide displays three distinct charts: two BLI sensorgrams (top left and bottom left) and one viscosity vs concentration scatter plot (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/17", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "before_after", "function": "analyze_data", "notes": "The slide demonstrates a progression from initial screening (DLS) to final stability assessment (monomer loss) to justify the selection of specific excipient combinations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/18", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a scatter plot, bar chart, line chart, and summary table comparing different stabilizer mixtures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/19", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "Includes a bar chart of DOE samples, a linear regression plot of pH vs monomer, and a heatmap of sugar vs pH.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/20", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/21", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-515b-7418-8f63-c88f7332de1c", "docSlug": "4cb2353e0dc8a61daa0b92defb28cc8a", "documentTitle": "Comera | Investor Presentation Deck | 22 slides", "authorId": "comera", "authorName": "Comera Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "closing_ask", "function": "closing_ask", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-515b-7418-8f63-c88f7332de1c/22", "deckHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c", "deckAnchorHref": "/decks/019de074-515b-7418-8f63-c88f7332de1c#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features a molecular visualization with a target reticle.", "imagePath": "https://imgproxy.kitesheet.com/aeWrWqMWubOfIFHs0Gb1mBEzCxf9wIGJ_IOOfQNGmmc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85Mjc5ZDE5MDIwZDJlOTUwMzJkYzM0YTEyN2FhYTJlNy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/1", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/gEVgUmmyf9YGdv-foJkQxCuJK3S8jCVBW_Mr_nfQCEs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85Mjc5ZDE5MDIwZDJlOTUwMzJkYzM0YTEyN2FhYTJlNy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/AvbE6HzpxS5dKvj4CLjSGWZBYttufu8lysu2L0yyDQU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85Mjc5ZDE5MDIwZDJlOTUwMzJkYzM0YTEyN2FhYTJlNy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/VsbcrTdwhMQCV9ic8Zyg0Difpzh3xbMrjf2lBvBwPxg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85Mjc5ZDE5MDIwZDJlOTUwMzJkYzM0YTEyN2FhYTJlNy9wMDAxLnBuZw" }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/2", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a ribbon-style list format to categorize key company information.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/3", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-3", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "590bd1fa-81fd-41c8-a6ed-e43bbd3fa487", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents an overview of the current state of cancer treatment and the need for innovative therapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a horizontal bar format to represent the development stage of various drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/4", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-4", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "590bd1fa-81fd-41c8-a6ed-e43bbd3fa487", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents an overview of the current state of cancer treatment and the need for innovative therapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to display headshots, names, titles, and a collection of logos representing past or associated company experience.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/5", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-5", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "590bd1fa-81fd-41c8-a6ed-e43bbd3fa487", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents an overview of the current state of cancer treatment and the need for innovative therapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 5, "from": 5, "beatId": "dbe93d26-ba8c-4987-a789-b96eff32586a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The document presents an overview of the leadership team.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": "The slide features a compass-like icon, suggesting a navigational or strategic focus for the upcoming section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/6", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-6", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The slide illustrates the mechanism of action of a bispecific antibody targeting DLL4 and VEGF-A.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/7", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-7", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "vision", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/8", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-8", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "MTD = Maximum Tolerated Dose; PR = Partial Response; RECIST = Response Evaluation Criteria in Solid Tumors; ORR = Objective Response Rate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/9", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-9", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The chart displays tumor growth percentages for individual patients, categorized by cancer type (Gastric, CRC, Other) and labeled with dosage (mpk).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/10", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-10", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "analyze_data", "notes": "The table highlights Partial Response (PR) rates with a red border.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/11", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-11", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The chart highlights a subset of patients with significant tumor reduction (boxed area).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/12", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-12", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding clinical trial context for hypertension and cytopenia.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/13", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-13", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "The slide presents clinical efficacy data comparing monotherapy vs combination therapy across two metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/14", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-14", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "d5e03937-35e0-480b-9c15-3a456dbe1e6a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents an overview of CTX-009, CTX-471, and CTX-8371, including their potential benefits and development plans.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide illustrates a standard Simon 2-Stage design, a common statistical framework for Phase II oncology trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/15", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-15", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table highlights patient age, gender, ECOG status, prior therapies, and cancer subtypes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/16", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-16", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "This is a standard oncology 'swimmer's plot' or 'waterfall plot' used to demonstrate clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/17", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-17", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Standard clinical trial swimmer plot visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/18", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-18", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Includes patient enrollment status and breakdown of ORR by prior lines of therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/19", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-19", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "Standard clinical trial survival analysis charts (Kaplan-Meier) with 'Number at risk' tables below.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/20", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-20", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide compares clinical trial data for a specific combination therapy against historical label data for individual components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/21", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-21", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The table compares a small sample size (N=24) against much larger historical cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/22", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-22", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a side-by-side comparison to highlight the superior ORR, PFS, and OS of CTX-009 compared to historical benchmarks like FOLFOX and TOPAZ-1.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/23", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-23", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a 2:1 randomized clinical trial structure for a drug combination (CTX-009 + Paclitaxel) versus a control (Paclitaxel).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/24", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-24", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a table for market sizing and a structured layout to contrast 1L and 2L treatment options.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/25", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-25", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "7116da44-3e6d-4946-b1fa-14f86e25b510", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents an overview of the market size and patient demographics for CTX-009.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide depicts a standard Simon 2-stage design, a common statistical framework in oncology clinical trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/26", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-26", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "7116da44-3e6d-4946-b1fa-14f86e25b510", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents an overview of the market size and patient demographics for CTX-009.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide provides epidemiological data alongside a clinical treatment landscape overview.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/27", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-27", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "7116da44-3e6d-4946-b1fa-14f86e25b510", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents an overview of the market size and patient demographics for CTX-009.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a three-column layout to represent sequential or parallel development tracks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/28", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-28", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/29", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-29", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "solution", "function": "present_solution", "notes": "Includes a molecular visualization showing the binding site of CTX-471 compared to other antibodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/30", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-30", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "testimonial", "function": "show_traction", "notes": "The slide uses a before-and-after visual comparison of CT scans to demonstrate drug efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/31", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-31", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/32", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-32", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/33", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-33", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to show the transition from testing bispecific formats to the identification of the lead candidate CTX-8371.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/34", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-34", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a visual comparison framework to contrast standard therapy (left) with the company's proprietary mechanism (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/35", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-35", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "traction", "function": "show_traction", "notes": "The slide shows tumor volume reduction over time, percentage tumor growth inhibition, and individual tumor response curves, highlighting CTX-8371's efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/36", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-36", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines the current progress and future clinical trial design for a drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/37", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-37", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/38", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-38", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a list-based structure to summarize drug development progress across three distinct assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/39", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-39", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "timeline", "function": "plan_implementation", "notes": "The timeline uses blue and red color coding for different drug programs or status types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/40", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-40", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/PsuxUftQNuU-scCabV6k7fCnuBAm0PYVQilPtl1Knkw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTU2MjgwMjA0NTczZTk3ZWY5OTA4YzMxNmVjZWE3Ni9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/1", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/NOOO7QBrx2rfl47M-hAmLJIyTU9Hl4LQ9SZDDWqSSTY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTU2MjgwMjA0NTczZTk3ZWY5OTA4YzMxNmVjZWE3Ni9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/EaFO1jkx5pKPv6rv48kUcydJ2agnDD08BOwiBYQc6_U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTU2MjgwMjA0NTczZTk3ZWY5OTA4YzMxNmVjZWE3Ni9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/5ltzZAU0W6jq7QkJv7TEWEdGD2MSlpP0Rsk8xl6JahA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTU2MjgwMjA0NTczZTk3ZWY5OTA4YzMxNmVjZWE3Ni9wMDAxLnBuZw" }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/2", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/3", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a bubble-based growth visualization to represent market size expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/4", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "51cfc228-00b0-4dfd-9f26-4ddce447b010", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 4 discusses the large and fast-growing commerce market in Korea", "position": 0, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "traction", "function": "show_traction", "notes": "The table uses a stair-step visual representation to highlight the compounding nature of cohort spending.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/5", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-5", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "traction", "function": "show_traction", "notes": "The chart uses a line graph to visualize cohort retention and expansion over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/6", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-6", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "traction", "function": "show_traction", "notes": "Data points represent millions of members at the end of each quarter.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/7", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-7", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "unfair_advantage", "function": "show_traction", "notes": "The chart illustrates the scale of fulfillment and logistics centers in Korea.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/8", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-8", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "Highlights 2020 and 2021 as 'Covid Years' with a visual overlay.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/9", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-9", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 9, "beatId": "d58455c2-f30a-4d8b-a4b6-846d20904aa7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 9-11 discuss Coupang's improving gross profit and margin, as well as its progression towards free cash flow positive", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/10", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-10", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 9, "beatId": "d58455c2-f30a-4d8b-a4b6-846d20904aa7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 9-11 discuss Coupang's improving gross profit and margin, as well as its progression towards free cash flow positive", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the company's financial trajectory and strategic levers for cash flow improvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/11", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-11", "loopMatches": [ { "to": 11, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "358e2e45-48d2-434a-a0ae-1634341633ef", "evidence": "The deck presents a series of slides showcasing Coupang's growth and financial performance, implying that not investing in Coupang could result in missed opportunities", "position": 0, "objective": "Highlight the benefits of investing in Coupang", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 5, "beatId": "4438a981-2ea9-4751-940b-adcb03775bc7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 5-11 showcase Coupang's traction in terms of customer growth, revenue, and financial performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 9, "beatId": "d58455c2-f30a-4d8b-a4b6-846d20904aa7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 9-11 discuss Coupang's improving gross profit and margin, as well as its progression towards free cash flow positive", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-52d0-7380-9e15-d36bb3ca2ead", "docSlug": "a156280204573e97ef9908c316ecea76", "documentTitle": "Coupang | Results Presentation Deck | 16 slides", "authorId": "coupang", "authorName": "Coupang", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "business_model", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-52d0-7380-9e15-d36bb3ca2ead/12", "deckHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead", "deckAnchorHref": "/decks/019de074-52d0-7380-9e15-d36bb3ca2ead#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }